Global Health – Research, Budgets, Challenges
Moderator: Dr. Barry Bloom – Harvard University
Dr. Todd Evans – Professor and Vice Chair for Research, Department of Surgery, Weill Cornell Medical College
Dr. Ihor Lemischka – Professor, Developmental and Regenerative Biology, Mount Sinai School of Medicine
Robert Orr – Assistant Under-Secretary General, Policy Coordination and Strategic Planning, United Nations
Dr. Yemi Adesokan – Founder and CEO, Pathogenica Inc.
Dr. Larry Young – Director, Center for Translational Social Neuroscience, Emory University
Dr. Shelia Ryan – Chairman, American International Health Alliance
In recent years, the medical attention of Western nations has expanded from disease prevention to include concern for the human environment, and further, to priorities concerning the health and maintenance of the body as the population ages, particularity with respect to the negative impacts of poor diet. For instance, in the United States the leading causes of death can be seen as: heart disease, malignant neoplasm (cancer), respiratory disease, cerebrovascular disease (stroke), unintentional accidents, Alzheimer’s disease and diabetes. The first two conditions on the list are responsible for 47% of total deaths. In the U.S., Alzheimer’s disease alone is projected to cause the death of 1/8 individuals over the age of 65 that have the disease, totaling approximately 5.4 million deaths. Age is also a factor with diabetes, where 26% of those over 65 were diagnosed with the disease in 2011. Similarly, over 77% of those diagnosed with cancer in the U.S. are identified as individuals 55 years or older, where men have been given a lifetime risk factor of 1 in 2, and women, 1 in 3. With these prevailing health challenges on the horizon, how far away are we from developing effective cures? Secondly, due to scale and cost of treating such diseases, how can national governments best cope with these challenges? How can effective methods be created that are not only cost effective, but can be effectively exported to those affected in the developing world?